Leap Therapeutics plunges on 10-for-1 reverse stock split

Cypherpunk Technologies

20/06/2023 19:33

** Shares of cancer drug developer Leap Therapeutics
 LPTX.O  fall 25% to $0.53
    ** Co announces 10-for-1 reverse stock split of its issued
and outstanding common stock    
    ** Stock set to post worst day since Nov. 8, if losses hold
    ** Co says reverse stock split implemented to meet Nasdaq's
listing requirements
    ** Expects stock to begin trading on split-adjusted basis
from June 21
    ** Including session's losses, stock has risen 20.2% YTD

 (Reporting by Sruthi Narasimha Chari in Bengaluru)
 ((Sruthinarasimha.chari@thomsonreuters.com))